Congress funds study to prevent TB transmission through organ transplants
H.R. 9561 — Shandra Eisenga TB Study Act of 2026 · Filed by John Moolenaar (R-MI) · 2 cosponsors · Introduced Jun 30, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to study whether a reliable test can be developed to detect tuberculosis in tissue from deceased donors, with the goal of improving organ and tissue transplant safety. The study must be completed within 2 years, involve consultation with the NIH, CDC, FDA, and organ procurement organizations, and result in a congressional report with recommendations within 3 years.
Why we flagged it
The bill is a straightforward appropriations-backed research mandate with no regulatory, tax, or private-benefit mechanisms. It directs a federal agency to conduct a feasibility study on a specific public-health problem (TB detection in cadaver tissue) and report findings to Congress.
What the text implies
- The study's recommendations may eventually lead to new FDA regulatory requirements for organ and tissue banks, potentially increasing compliance costs for procurement organizations and tissue banks — a secondary effect not explicit in the bill itself.
- Naming the bill after Shandra Eisenga (a deceased individual) suggests a personal or memorial motivation, though the bill text does not explain the connection or whether Eisenga was affected by TB transmission through transplant.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill funds a public-health study aimed at preventing tuberculosis transmission through organ and tissue transplants, protecting both transplant recipients and the integrity of the donation system. There are no restrictions on citizen rights, no private giveaways, and no hidden costs to the public.
Who stands to gain
- organ procurement organizations (study participants and potential future implementers)
- tissue banks (study participants and potential future implementers)
- medical device/diagnostic companies (if a test is eventually developed and commercialized)
Named in the bill
Department of Health and Human Services, National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, organ procurement organizations, tissue banks, medical examiners
Where it stands
2 cosponsors: 2 Democrats.
- Jun 30, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jun 30, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (2,836 characters) on Aug 12, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress funds study to prevent TB transmission through organ transplants” QuorumCivic. https://share.quorumcivic.app/bill/119/hr9561 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.